Silver Book reference

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-year randomized controlled trial

1 Matching Fact

Search matching Facts:
No results to display
    • One study found that dopaminergenic therapies for Parkinson’s disease patients resulted in lower dyskinesias as well as lower incidences of freezing, drowsiness, and edema–resulting in better quality-of-life through symptom control.